Together with the Institute for Competitiveness India, Schott and EBTC, The Netherlands Center of Competitiveness is organizing a workshop “An Indian Innovation Journey” on May 3rd, 2013 at The Leela Kempinski, Gurgaon.
The focus of the program will be on methods of innovation, specifically the Indian and Global developments of frugal innovation. Several trends stemming from frugal innovation are shaping different industries: Energy & Energy Solutions, Water-water management-purification, real estate –development & construction, mobile – devices and technologies etc. Lead by industry experts, the workshop will guide participants through discussions, group work, keynotes, exercises and much more to learn from the global, Indian and European insights about frugal innovation.Continue reading
Prof. Dr. Fred van Eenennaam joins the Microeconomics of Competitiveness Affiliate Network Hall of Fame
We are delighted to announce that Prof. Dr. Fred van Eenennaam, partner of The Decision Group, has been put in the limelight by Prof. Dr. Michael Porter. Because of his contribution to the pragmatics of and research in the competitiveness of clusters, as well as his extensive involvement in the worldwide MOC network, Prof. Dr. Fred van Eenennaam is now included in the Microeconomics of Competitiveness Affiliate Network Hall of Fame. We are proud of this unexpected honour, and we see it as an encouragement to continue to offer our expertise to all who can use it to their advantage.
Visit our dedicated website to learn more on Competitiveness & Clusters!
The Netherlands Institute for Competitiveness
Furthermore, we are pleased and excited to announce that in December 2012, we have launched the Netherlands Institute for Competitiveness. The Institute could not have been established without the help from our international academic colleagues. It is the logical consequence of the experiences in the past. The center combines the international network of cluster organizations with academic and pragmatic expertise on international business. The aim of the Netherlands Institute for Competitiveness is to provide expertise, access and knowledge to 1) companies that wish to build their international business and 2) academic institutes that wish to increase their knowledge.
We invite you to take a look at our website.Continue reading
“Understand your customers, your own DNA and design your own business model! But formost, timing. Timing of strategic moves is crucial.” These were the two main conclusions of case teacher and innovation expert Ir. Maarten Koomans during the workshop Innovation & Growth of the Strategy & Governance Excellence Series of affiliate The Decision Institute.
Apple Inc as best practice
Take Apple. It has been a rocky-ride for most of their existence. Sure, now they are the most valueable company with a P/E of 13, but not always. What connects their NOW with their PAST is the profile of their customer base, innovation capabilities combined with their own true understanding of design and users. The Intel move should not have happened two years earlier or later. Both would have been disasterous. The Business Model Canvas serves in this discussion as a super conversation tool to understand where your core is, and where you might look to find a starting point for new approaches/products/services.
Continuously, business environments change; new competitors enter the market, new technologies appear and other substitution services or products reach your clients. To stay ahead of the curve, it is necessary to think about your business model over and over again.
- What is the added value for the client?
- What are the key activities of the business?
- What are the costdrivers of the business?
Partnering with Business Models Inc., The Decision Group can visualize and develop a value proposition for your business, with the tool: Advanced Business Model Canvas.
For more information about the Strategy & Governance Excellence Series of affiliate The Decision Institute, can be found on our website.Continue reading
Prosensa is a succesful biotech company in the Dutch Life Sciences Cluster. In January 2012 it closed the Series C round and raised another $30 million, by a large international investor. Prosensa has grown from a small startup to a renowned Dutch biotech company in the development of a treatment from “bench to bed” for orphan diseases.
Partner The Decision Institute has written a Harvard Style Business Case about the company and its search for a treatment for Duchenne Muscular Dystrophy, a rare genetic disorder. The objective is to demonstrate the best practices of the Dutch biotech cluster. What can we learn from Prosensa and the biotech cluster? What are their strategies to bind large investors? Thanks to Leiden University, LSH, LUMC, NGI, PGGM, Prosensa, The Decision Institute and expecially all interviewees and editors who made it possible to develop the The Prosensa Case; Pioneering & Partnering. The case and the experiences of The Decision Group can help you to bind international partnerships for your strategic next steps.
Biotech and The Decision Group.
Since 1998, extensive expertise is built in biotech and life sciences. Out portfolio contains a wide range of projects for big pharma, medical device companies and biotech companies. Scenario analysis and strategic reviews as well as helping to create patient centered relations with customers and realizing growthpotential in the cost-cutting market..
Furthermore, The Decision Group monitors clusters success in Life Sciences & Health. The Dutch Life Sciences & Health Outlook measures performance and progress of the industry and benchmarks with succesful clusters worldwide. The aim of the Outlook 2013 is also to address the convergence to healthcare. Innovation from Bench to Bed.
- Learn more on scenario planning and cluster monitoring by visiting the website advanced strategic tools.
- Request your copy of the Dutch Life Sciences Outlook here.
- Send an e-mail to Kim Bruheim to learn more on the possibilities with the new case.
- See also:
Executive programs:Continue reading
– Strategy & Governance Excellence Series
In the effort to help the internationalization of the Dutch flower cluster further, a workshop with case discussion was provided by Partner of The Decision Group at the International University of Monaco. The potential of Dutch flowers as a luxury good were explored during case discussion of the Harvard Business Case on the cluster. The Dutch Flower Cluster is one of the top clusters in the Netherlands, a designated “topgebied” for innovation policy.
The Decision Group and Clusters and Competitiveness
Since 1998, The Decision Group has developed extensive expertise on Clusters and Competitiveness. The Decision Group has helped monitoring clusters success, developed strategic plans and scenario’s and is active in association management. Furthermore, advanced strategic tools as Scenario 3.0 and the Decision Lab 3.0 are developed to help you to make your business decisions and to improve your competitive advantage. Our work on clusters and competitiveness has academic grounding through our connects to Prof. Michael Porter and his Microeconomics of Competitiveness course and international network, linked with HBS’s Institute for Strategy & Competitiveness.
The Decision Group Strategy Consulting on Competitiveness & Clusters:Continue reading
– Consulting on Competitiveness & Clusters
– Decision lab 3.0
– Monitoring Succes of the Dutch Life Sciences Cluster
Following the positive response on the Dutch Life Sciences Outook 2012, The Decision Group just started the development of the Outlook 2013. The database is updated again, startup companies are added and new developments are analyzed. The Academic Council will meet as well for thorough academic grounding of our theoretic models and validation of our methodologies. We expect that the new outlook will be launched in Januari, 2013.
Healthcare Section in Outlook 2013
The aim of the new outlook 2013 is to address the convergence of innovation in healthcare. At this stage, The Decision Group is exploring options and opportunities for including a healthcare section in the outlook. A partner has already been selected.
For questions, suggestion or more information about the Outlook 2013, please contact Niels van Gorp, ir.
The Dutch Life Sciences Outlook of 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.
See alsoContinue reading
Prof. Dr. Fred van Eenennaam, partner of The Decision Group and Dirk Hogervorst, of FloraHolland, acted as case protagonists in Prof. Michael Porters’s teaching of the Dutch Flower Cluster case. The topics discussed were on strategies in clusters and competitiveness in relation to the Dutch Economy. The Dutch Flower Cluster Case, the succes story of the flower industry in The Netherlands, is a Harvard Business School case written by Prof. Porter, Dr. Ramirez-Vallejo and Prof. Dr. Fred van Eenennaam with the help of Dirk Hogervorst of FloraHolland. The flower industry is important for the Dutch economy and part of the topsector horticulture & propagation materials. With topsectors, the Dutch government has set a focus on core clusters for innovation policy.
The Decision Group and Clusters and Competitiveness
The Decision Group has extensive expertise in competitiveness, clusters and associations. Our work in clusters has academic grounding through Prof. Dr. Fred van Eenennaam’s connects to Harvard’s Microeconomics of Competitiveness course and international network. The Decision Group helps monitoring clusters success, develops strategic plans and scenario’s, and is active in association management. For 4 years now, The Decision Group develops a yearly Outlook for the Dutch Life Science Health cluster, monitoring performance & progress with recommendations for future improvement. The Decision Group just started development of the Dutch Life Sciences & Health Outlook 2013.
The Decision Group Strategy Consulting on Competitiveness & Clusters:
– Consulting on Competitiveness & Clusters
The Dutch Life Sciences Outlook:Continue reading
– Outlook 2012
Most attention was paid to the survey-based forecasts that start-up and smaller companies in the biotechnology will get under high pressure if they don’t get access to private and public investments. Contrary to the focus chosen by Dutch newspapers, the key conclusions from the Outlook 2012 according to The Decision Group are:
- Growth and outperformance: The Dutch lsh cluster shows growth in size and products and ouperforms the Dutch economy on growth in number of companies and employment.
- Positive Expectations: Entrepreneurs have positive expectations of the future despite disappearence of large companies.
- Partnering: Facilitating (international) partnerships remains very important or future growth of the companies in the Dutch lsh cluster.
Het Financieel Dagblad, the newspaper with an economic and financial focus, spent two articles on the Dutch Life Science Outlook 2012:
– Geldstroom ‘life sciences’ dreigt op te drogen – FD of Thursday 19 January 2012, page 14
– Subsidie schraagt groei life sciences – FD of Monday 23 January 2012
Furthermore, a special news item about the changes in the Life Sciences Sector based on the Outlook, was broadcast by RTL Z, the financial news channel.
Life Sciences and The Decision Group
The Decision Group has extensive expertise on Life Sciences. Our client list includes many companies in big pharma as well as in medical devices and biotech. This expertise is underlined by the yearly published Dutch Life Sciences Outlook.
More information about The Decision Group’s work on Life Sciences can be found on our special website.Continue reading
The Dutch Life Sciences Outlook 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.
Official press release of Outlook 2012 by Life Science & Health: Stijging aantal bedrijven en werkgelegenheid biotech sector
On Wednesday January 18th, Prof. dr. F. van Eenennaam, partner of The Decision Group, presented the Dutch Life Sciences Outlook for a group of 60 key stakeholders in Life Sciences. The Outlook yearly monitors Dutch Life Sciences & Health Cluster success and measures performance and progress of the sector. This yearly systematic Outlook is created in close collaboration between The Decision Group and Life Sciences Health.
Clusters & Competitiveness
Prior to presenting the Outlook, Prof dr. F. van Eenennaam gave a Masterclass on Cluster Development, where theory and practicalities of clusters were discussed, as well as implications for Dutch policy makers. The Decision Group has extensive expertise on Clusters & Competitiveness. See also our Clusters & Competitiveness website
The Dutch Life Sciences Outlook 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.Continue reading
In the December edition of VM (Verenigingsmanagement Magazine; Click to download the full article), Prof. dr. Fred van Eenennaam, ir. Roald van Leeuwen and ir. Niels van Gorp set an outline on how to stay ‘ahead of the curve’ in association management. The underlying question is: how to deal with increased uncertainty while keeping up with the rapid speed of changing environment. The suggestions and practical tips are illustrated by best practices of the shape strategy in diverse industries. In the article, Dirk Hogervorst of FloraHolland shares insights on moments of truth for the cooperative flower auction and on how they manage to stay ahead of the curve as a cluster.
The Decision Group and Association Management
Since 1998, The Decision Group has extensive expertise in projects on Clusters and Competitiveness. The Decision Group has helped monitoring clusters success, developed strategic plans and scenario’s and is active in association management. Our work in clusters has academic grounding through Prof. Dr. Fred van Eenennaam’s connects to Harvard’s Microeconomics of Competitiveness course and international network.
More information of our approach and examples about Association Management and Clusters can be found in on this page.Continue reading